. . . . "G,12,V" . . . . . . . . . . . . . . . . "a(SCHEM:U0126) -| (p(HGNC:HRAS,sub(G,12,V)) -> p(HGNC:MAPK1,pmod(P,T,185)))" . "p(HGNC:HRAS,sub(G,12,V)) -> p(HGNC:MAPK1,pmod(P,T,185))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Ras-mediated activation of ERK activity (represented by the phosphorylation status of ERK1/2 Thr202/ Tyr204) and of RSK activity (represented by the phosphorylation status of RSK1 Ser380) could efficiently be blocked by U0126 treatment (Figure 4a)." . . "Selventa" . . . . "2014-07-03T14:30:51.965+02:00"^^ . . .